rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    PEN
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Penumbra (PEN) Stock Faces Q3 Earnings Valuation Scrutiny
      Oct 31Yahoo FinancePEN
      Penumbra Inc earnings missed by $0.13, revenue topped estimates
      Oct 29Investing.comPEN
      Penumbra: Q3 Earnings Snapshot
      Oct 29Yahoo FinancePEN
      FDA clears Penumbra’s CAVT technology for DVT treatment
      Oct 20Investing.comPEN
      Penumbra's CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT)
      Oct 20Yahoo FinancePEN
      Penumbra (PEN) Clinical Data Puts Its Valuation Back In Focus
      Oct 8Yahoo FinancePEN
      Reasons to Retain Penumbra Stock in Your Portfolio for Now

      PEN's portfolio expansion and international growth support momentum, while rising costs, FX exposure and margin pressure remain key risks.

      Sep 16Yahoo FinancePEN
      Boston Scientific Leans on Acquisitions to Drive Long-Term Growth
      Sep 14Yahoo FinancePEN

      This is the newest page. Registered accounts read further back.